ESH Video

EXTENDED DEADLINE FOR ABSTRACTS: MAY 17, 2020 - JOHN GOLDMAN CONFERENCE

May 05, 2020

22nd ANNUAL JOHN GOLDMAN CONFERENCE ON
CHRONIC MYELOID LEUKEMIA:
BIOLOGY AND THERAPY


 

October 2-4, 2020
Mandelieu-La Napoule, France
 

Chairs: Jorge Cortes, Tim P. Hughes, Daniela S. Krause

Co-organizers: Ravi Bhatia, Tim Brümmendorf, Mhairi Copland, Michael Deininger, Olivier Hantschel, François-Xavier Mahon, Danilo Perrotti, Jerry Radich, Delphine Réa

Advisory CommitteeJane Apperley, Susan Branford, Carlo Gambacorti-Passerini, François Guilhot, Rüdiger Hehlmann, Pierre Laneuville, Giuseppe Saglio, Charles Schiffer, Simona Soverini, Peter Valent,
Rick Van Etten
 

 
EXTENDED DEADLINE FOR ABSTRACTS
FOR ORAL AND POSTER PRESENTATIONS:


May 17, 2020
 
 
 
 

 
ABOUT THE PROGRAMME:

Speakers at this meeting will present the newest and often unpublished data relating to the (1) Biology of CML including the origin of BCR-ABL1, signal transduction, basis of disease progression, action of tyrosine kinase inhibitors and mechanisms underlying resistance to TKI, and (2) aspects of treatment including prediction and definition of responses, drugs used in combination, modern diagnostics and molecular monitoring, targeting residual stem cells, approaches to cure and treatment free remission.

The programme will include:

  • John Goldman Prize lecture
  • Janet Rowley Prize lecture
  • iCMLf Prize lecture
  • Keynote lectures
  • Special lectures
  • Workshops for non-clinical scientists
  • Oral communications selected from submitted abstracts
  • Brief oral communications selected from submitted abstracts
  • Meet-the-Expert Sessions
  • Clinical and biology Manned Poster Walks
  • Special Saturday symposium 2020
  • The ESH International John Goldman Research Award presentation 2020

Main Topics:

- Stem Cells and the microenvironment
- Molecular biology and new targets
- Proteomics and Secretomics
- Artificial Intelligence and Machine Learning
- Mechanisms of resistance and disease progression
- Biomarkers
- Immunology and Inflammation
- Therapeutic interventions
- Immunotherapy
- Treatment free remission
- Safety and patient reported outcomes
- Clinical trial design
- The new ELN recommendations
- New drugs in development
 
To register and for more information CLICK HERE
 

 
LEUKAEMIA UK INTERNATIONAL SCHOLARSHIPS

This Call for Applications is made thanks to a funding support from:

The present  Call for Applications may be of interest to you if you are:

Extended deadline for applications:
May 17, 2020
 
 

Stay tuned for announcements regarding other ESH Scholarship Fund scholarships.
 

 
With the support of*:

                        
Emerald Conference Partners
********

Ruby Conference Partner
********

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.